BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11690684)

  • 1. Proton RBE for early intestinal tolerance in mice after fractionated irradiation.
    Gueulette J; Slabbert JP; Böhm L; De Coster BM; Rosier JF; Octave-Prignot M; Ruifrok A; Schreuder AN; Wambersie A; Scalliet P; Jones DT
    Radiother Oncol; 2001 Nov; 61(2):177-84. PubMed ID: 11690684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton relative biological effectiveness (RBE) for survival in mice after thoracic irradiation with fractionated doses.
    Gueulette J; Bohm L; Slabbert JP; De Coster BM; Rutherfoord GS; Ruifrok A; Octave-Prignot M; Binns PJ; Schreuder AN; Symons JE; Scalliet P; Jones DT
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):1051-8. PubMed ID: 10863078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal crypt regeneration in mice: a biological system for quality assurance in non-conventional radiation therapy.
    Gueulette J; Octave-Prignot M; De Costera BM; Wambersie A; Grégoire V
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S148-54. PubMed ID: 15971332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative biologic effectiveness determination in mouse intestine for scanning proton beam at Paul Scherrer Institute, Switzerland. Influence of motion.
    Gueulette J; Blattmann H; Pedroni E; Coray A; De Coster BM; Mahy P; Wambersie A; Goitein G
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):838-45. PubMed ID: 15936568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurements of radiobiological effectiveness in the 85 MeV proton beam produced at the cyclotron CYCLONE of Louvain-la-Neuve, Belgium.
    Gueulette J; Grégoire V; Octave-Prignot M; Wambersie A
    Radiat Res; 1996 Jan; 145(1):70-4. PubMed ID: 8532839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RBE variation as a function of depth in the 200-MeV proton beam produced at the National Accelerator Centre in Faure (South Africa).
    Gueulette J; Böhm L; De Coster BM; Vynckier S; Octave-Prignot M; Schreuder AN; Symons JE; Jones DT; Wambersie A; Scalliet P
    Radiother Oncol; 1997 Mar; 42(3):303-9. PubMed ID: 9155083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiobiological intercomparison of the 160 MeV and 230 MeV proton therapy beams at the Harvard Cyclotron Laboratory and at Massachusetts General Hospital.
    Wouters BG; Skarsgard LD; Gerweck LE; Carabe-Fernandez A; Wong M; Durand RE; Nielson D; Bussiere MR; Wagner M; Biggs P; Paganetti H; Suit HD
    Radiat Res; 2015 Feb; 183(2):174-87. PubMed ID: 25587741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo radiobiological characterization of proton beam at the National Cancer Center in Korea: effect of the Chk2 mutation.
    Kim SS; Choo DW; Shin D; Baek HJ; Kim TH; Motoyama N; De Coster BM; Gueulette J; Furusawa Y; Ando K; Cho KH
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):559-62. PubMed ID: 21195877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematics of relative biological effectiveness measurements for proton radiation along the spread out Bragg peak: experimental validation of the local effect model.
    Grün R; Friedrich T; Krämer M; Scholz M
    Phys Med Biol; 2017 Feb; 62(3):890-908. PubMed ID: 28072575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear interactions in proton therapy: dose and relative biological effect distributions originating from primary and secondary particles.
    Paganetti H
    Phys Med Biol; 2002 Mar; 47(5):747-64. PubMed ID: 11931469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calculation of relative biological effectiveness for proton beams using biological weighting functions.
    Paganetti H; Olko P; Kobus H; Becker R; Schmitz T; Waligorski MP; Filges D; Müller-Gärtner HW
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):719-29. PubMed ID: 9112472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative biological effectiveness (RBE) values for proton beam therapy.
    Paganetti H; Niemierko A; Ancukiewicz M; Gerweck LE; Goitein M; Loeffler JS; Suit HD
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):407-21. PubMed ID: 12023146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance and implementation of RBE variations in proton beam therapy.
    Paganetti H
    Technol Cancer Res Treat; 2003 Oct; 2(5):413-26. PubMed ID: 14529306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the Implications of a Variable RBE on Proton Dose Fractionation Across a Clinical Pencil Beam Scanned Spread-Out Bragg Peak.
    Marshall TI; Chaudhary P; Michaelidesová A; Vachelová J; Davídková M; Vondráček V; Schettino G; Prise KM
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):70-77. PubMed ID: 27084630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative biological effectiveness (RBE) and distal edge effects of proton radiation on early damage in vivo.
    Sørensen BS; Bassler N; Nielsen S; Horsman MR; Grzanka L; Spejlborg H; Swakoń J; Olko P; Overgaard J
    Acta Oncol; 2017 Nov; 56(11):1387-1391. PubMed ID: 28830292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative biological effectiveness of the 235 MeV proton beams at the National Cancer Center Hospital East.
    Ando K; Furusawa Y; Suzuki M; Nojima K; Majima H; Koike S; Aoki M; Shimizu W; Futami Y; Ogino T; Murayama S; Ikeda H
    J Radiat Res; 2001 Mar; 42(1):79-89. PubMed ID: 11393892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative biological effectiveness of proton beams in clinical therapy.
    Gerweck LE; Kozin SV
    Radiother Oncol; 1999 Feb; 50(2):135-42. PubMed ID: 10368035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractionated carbon ion irradiations of the rat spinal cord: comparison of the relative biological effectiveness with predictions of the local effect model.
    Saager M; Glowa C; Peschke P; Brons S; Grün R; Scholz M; Debus J; Karger CP
    Radiat Oncol; 2020 Jan; 15(1):6. PubMed ID: 31900185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of a radioresistant human melanoma cell line along the proton spread-out Bragg peak.
    Petrović I; Ristić-Fira A; Todorović D; Korićanac L; Valastro L; Cirrone P; Cuttone G
    Int J Radiat Biol; 2010 Sep; 86(9):742-51. PubMed ID: 20597839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam.
    Britten RA; Nazaryan V; Davis LK; Klein SB; Nichiporov D; Mendonca MS; Wolanski M; Nie X; George J; Keppel C
    Radiat Res; 2013 Jan; 179(1):21-8. PubMed ID: 23148508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.